Evaluation of the BodyGuardian End-to-end Remote Monitoring Platform in an Outpatient Heart Failure Population

Overview

About this study

We will evaluate the end to end remote monitoring system in a less controlled environment and concurrently develop the infrastructure to support the back end of the system

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Outpatients
  • Stable NYHA Class I-III HF (defined as no admissions for > 1 year)
  • Recruited from the Mayo Heart Failure Clinic, including 15 men and 15 women
  • Age > 50 years
  • Reside in Olmsted County

Exclusion Criteria:

  • Hospital admission for HF within past year
  • Dementia
  • Overall life expectancy < 1 year
  • Blindness
  • Pregnancy or women able to become pregnant
  • Skin allergy to adhesives
  • Inadequate cell phone coverage (international patients or international travel during study period)
  • Documented EF of >40%

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Lyle Olson, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions